Experimental Drug May Extend Lung Cancer Survival, Study Suggests

SATURDAY May 31, 2014, 2014 — A new “targeted” therapy might help extend the lives of patients with advanced lung cancer who have a relapse after their initial treatment, a clinical trial suggests. The drug, ramucirumab, improved survival by more than a month when combined with…

Source:Experimental Drug May Extend Lung Cancer Survival, Study Suggests